Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

Endpoint:
developmental toxicity
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable, well documented study which meets basic scientific principles. Taken from OECD SIDS on Sodium bicarbonate (2002), where a similar reliability was assigned

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1974

Materials and methods

Principles of method if other than guideline:
Aqueous solutions of sodium bicarbonate were administered daily via oral intubation to pregnant rats at doses ranging from 3.4-340 mg/kg bw mg/kg bw during days 6-15 of gestation. The fetuses were examined for the presence of external congenital abnormalities, detailed visceral abnormalities and for skeletal defects.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Reference substance name:
sodium bicarbonate
IUPAC Name:
sodium bicarbonate

Test animals

Species:
rat
Strain:
Wistar
Details on test animals or test system and environmental conditions:
- Strain: Albino Wistar derived rats.

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Duration of treatment / exposure:
Day 6 - day 15 of gestation
Frequency of treatment:
once daily
Doses / concentrationsopen allclose all
Remarks:
Doses / Concentrations:
0
Basis:
no data
Remarks:
Doses / Concentrations:
3.4 mg/kg
Basis:
no data
Remarks:
Doses / Concentrations:
15.8 mg/kg
Basis:
no data
Remarks:
Doses / Concentrations:
73.3 mg/kg
Basis:
no data
Remarks:
Doses / Concentrations:
340 mg/kg
Basis:
no data
Control animals:
yes
Details on study design:
sex: female

Results and discussion

Results: maternal animals

Effect levels (maternal animals)

Dose descriptor:
NOAEL
Effect level:
>= 340 mg/kg bw/day (actual dose received)
Based on:
no data
Basis for effect level:
other: developmental toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:no effects

Fetal abnormalities

Abnormalities:
not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Any other information on results incl. tables

NOAEL: 340 mg/kg

ACTUAL DOSE RECEIVED BY DOSE LEVEL BY SEX:

Not reported. TOXIC RESPONSE/EFFECTS BY DOSE LEVEL:

----------------------------------------------------------------------

Dose (mg/kg): Sham Aspirin 3.4 15.8 73.3 340

----------------------------------------------------------------------

Pregnancies 20 24 20 21 21 22

Died or aborted 1 0 0 0 0 0

Live litters 19 19 20 21 21 22

Implant sites 226 277 239 268 238 254

Resorptions 5 93 3 0 0 1

Live fetuses 221 183 236 268 237 251

Dead fetuses 0 1 0 0 1 2

Fetus weight (g) 3.57 2.53 3.66 3.80 3.85 3.72

---------------------------------------------------------------------

- Effects on offspring: The number of abnormalities seen in either soft or skeletal tissues of the test groups did not differfrom the number occurring spontaneously in the sham-treated controls.

Applicant's summary and conclusion